In vitro activity of Amphotericin B against zygomycetes isolated from deep mycoses: a comparative study between incubation in aerobic and hyperbaric atmosphere

References

• Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin North Am 2002; 16: 895–914.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Walsh TJ, Kontoyiannis DP, . Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48: 1743–1751.
   PubMed Web of Science ®Google Scholar
• Duplechain JK, White JA. Mucormycosis of the head and neck. J La State Med Soc 1989; 141: 9–13.
   Google Scholar
• Gordon G, Indeck M, Bross J, . Injury from silage wagon accident complicated by mucormycosis. J Trauma 1988; 28: 866–867.
   PubMedGoogle Scholar
• Price JC, Stevens DL. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 1980; 90 (Pt1): 737–747.
   Google Scholar
• Bentur Y, Shupak A, Ramon Y, . Hyperbaric oxygen therapy for cutaneous/soft-tissue zygomycosis complicating diabetes mellitus. Plast Reconstr Surg 1998; 102: 822–824.
   Google Scholar
• Blaine DA, Frable MA. Mucormycosis. Adjunctive therapy with hydrogen peroxide. Va Med Q 1996; 123: 30–32.
   Google Scholar
• De La Paz MA, Patrinelv JR, Marines HM, . Adjunctive hyperbaric oxygen in the treatment of bilateral cerebro-rhino-orbital mucormycosis. Am J Ophthalmol 1992; 114: 208–211.
   Google Scholar
• Kajs-Wyllie M. Hyperbaric oxygen therapy for rhinocerebral fungal infection. J Neurosci Nurs 1995; 27: 174–181.
   PubMedGoogle Scholar
• Melero M, Kaimen Maciel I, Tiraboschi N, . Adjunctive treatment with hyperbaric oxygen in a patient with rhino-sinuso-orbital mucormycosis. Medicina (B Aires) 1991; 51: 53–55.
   Google Scholar
• Hamilton JF, Bartkowski HB, Rock JP. Management of CNS mucormycosis in the pediatric patient. Pediatr Neurosurg 2003; 38: 212–215.
   Google Scholar
• Pelton RW, Peterson EA, Patel BC, . Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities. Ophthal Plast Recontr Surg 2001; 17: 62–66.
   PubMed Web of Science ®Google Scholar
• Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25: 215–229.
   PubMed Web of Science ®Google Scholar
• Segal E, Menhusen MJ, Shawn S. Hyperbaric oxygen in the treatment of invasive fungal infections: a single-center experience. Isr Med Assoc J 2007; 9: 355–357.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standard Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, Approved Standard (2nd ed.), M38-A2. Wayne, PA: Clinical and Laboratory Standard Institute; 2007.
   Google Scholar
• Anonymous. Hyperbaric oxygen halts Rhizopus infection. J Am Med Assoc 1979; 242: 314.
   Google Scholar
• Ferguson BJ, Mitchell TG, Moon R, . Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 1988; 10: 551–559.
   PubMedGoogle Scholar
• Newton WD, Cramer FS, Norwood SH. Necrotizing fasciitis from invasive Phycomycetes. Crit Care Med 1987; 15: 331–332.
   PubMedGoogle Scholar
• Pfaller MA, Marco F, Messer SA, . In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis 1998; 30: 251–255.
   PubMed Web of Science ®Google Scholar
• Riesselman MH, Hazen KC, Cutler JE. Determination of antifungal MICs by a rapid susceptibility assay. J Clin Microbiol 2000; 38: 333–340.
   PubMed Web of Science ®Google Scholar
• John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 2005; 11: 515–517.
   PubMed Web of Science ®Google Scholar
• Bullen JJ, Rogers HJ, Spalding PB, . Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol 2006; 55 (Pt3): 251–258.
   Google Scholar
• Barratt DM, Van Meter K, Asmar P, . Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model. Antimicrob Agents Chemother 2001; 45: 3601–3602.
   Google Scholar
• Clark JM, Lambertsen CJ. Tale of development of pulmonary O2 toxicity in man during O2 breathing at 2.0 ATA. J Appl Physiol 1971; 30: 739–752.
   PubMed Web of Science ®Google Scholar